Ultrastructure of junctional epidermolysis bullosa in Belgian foals.

The researchers conducted an ultra-structural examination of a likely hereditary skin disorder in Belgian foals that causes blistering, called Junctional Epidermolysis Bullosa (JEB). They found that the disorder caused separation at a specific part of the skin’s structure, similar to how JEB manifests in humans.

Understanding Junctional Epidermolysis Bullosa (JEB)

• JEB is a group of skin conditions in which skin layers detach from each other, leading to blister formation.
• It’s considered primarily a hereditary condition and is recognized in both human and veterinary medicine.
• The disease manifests similar characteristics in both humans and animals, particularly at the cellular level.

Key Findings of the Research

• The researchers found that in Belgian foals affected by the disorder, the separation occurs within the lamina lucida of the skin’s basement membrane. This is a very specific region situated between the outermost layer of skin (epidermis) and the next layer (dermis).
• The lamina densa, another part of the basement membrane, remains unharmed and still attached to the dermis, as does the plasmalemma of the basal epithelial cells. This observation showed a specific pattern of damage brought about by the disease.
• Further, small structures known as hemidesmosomes, which facilitate the attachment between cellular structures, were detected in the intact skin adjacent to the affected skin. This suggests that while the disease causes a certain level of damage, it doesn’t altogether destroy the cellular structures required for skin cohesion.

Comparison to Human JEB

• The researchers found clear similarities between how the disease manifests in Belgian foals and in human patients.
• Both conditions feature damage within the lamina lucida, with other aspects of the skin’s structure remaining relatively intact.
• These similarities suggest that studies in Belgian foals could potentially offer insights to improving understanding of the condition in humans and possibly identify new treatment strategies.